Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Ultra-Low Temperature Freezer

By Drug Discovery Trends Editor | September 27, 2012

Binder UF V ultra-low temperature freezers with Ultra.Guard technology are designed specifically for demanding laboratory environments. The freezers combine operational safety, ease of use, monitored access and low noise levels to produce the most secure long-term sample storage at temperatures to -86°C. A range of features deliver performance, safety and environmental benefits.

Data.Secure data logger, a highly flexible recording system, offers a modern replacement for the traditional chart recorder. A USB connection enables easy data transmission, requires no extra software and supports FDA guideline 21 CFR part 11 compliance. An integrated temperature sensor provides redundant temperature monitoring independent of the freezer controller.

Multiple outputs are available and seamlessly integrate into existing alarm systems. 
Optional features such as a back-up emergency CO2 refrigeration system and alarm notification via text message add an additional level of security.

Guard.Control optional RFID monitoring system offers a further layer of security by controlling access to the freezer contents, unlocking the door only for authorized personnel and automatically logging all freezer traffic.

Vacuum insulation panels create a reliable, energy-efficient environment for sample storage. The panels insulate a large surface area on all six sides of the freezer. The resulting streamlined form maximizes internal storage space while minimizing the freezer’s footprint.

Binder freezers accommodate as many as 52,800 samples. Model UF V 500 has a 460-liter/16.2 cu.ft. interior volume, and model UF V 700 a 685-liter/24.2 cu.ft. interior volume. Inner chambers are made of high-quality stainless steel, each with four compartments and three shelves. A two-stage cascade refrigeration system with hermetically sealed compressors uses non-flammable CFC-free refrigerant. The UF V 500 requires only 12.8 kWh per day for operation.

Ultra.Guard UF V freezers set a new standard with a sound pressure level of just 50 dB(A), making  them comfortable to operate within the laboratory. Lockable, heavy-duty casters permit the units to be easily moved by one person. Front access air filters are easy to clean. A heated duplex door gasket prevents icing. For greatly reduced heat emissions and even quieter operation, a water-cooled option is available.

Recycled heated water can even be fed back to the facility, increasing the environmental benefits while reducing operating costs.

Binder


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE